Ozempic is highly effective at producing weight loss, but it’s not actually approved for that purpose. The FDA approved Ozempic specifically for type 2 diabetes management, not weight management. Its identical active ingredient, semaglutide, is approved for weight loss under the brand name Wegovy at a higher dose. That said, many doctors prescribe Ozempic off-label for weight loss, and the drug’s ability to reduce body weight is well established in clinical research.
How Much Weight You Can Expect to Lose
Clinical trials show that semaglutide produces significant, sustained weight loss over time. In the first month, people typically lose about 3 to 4% of their starting body weight. For someone weighing 220 pounds, that’s roughly 7 to 9 pounds in the first four weeks.
The results build from there. By three months, participants in major trials had lost about 9.6% of their body weight. By 68 weeks (roughly 16 months), average weight loss reached nearly 15%. In a two-year study, patients taking semaglutide at the higher Wegovy dose lost a mean of 15% of their body weight, or about 34 pounds, from a starting average BMI of 38.5.
These are averages. Some people lose considerably more, others less. Individual results depend on starting weight, diet, activity level, and how well you tolerate the medication at higher doses.
How It Works in Your Body
Semaglutide mimics a natural hormone called GLP-1 that your gut releases after eating. When you inject it once a week, it activates GLP-1 receptors throughout your body, triggering a cascade of effects that reduce hunger and help you feel full on less food.
In the brain, semaglutide turns up the activity of appetite-suppressing signals while turning down appetite-stimulating ones. It also acts on brain regions that regulate hunger drive and energy balance, dampening the neurons that normally push you to seek food. The net effect: you genuinely feel less hungry and more satisfied after smaller meals. People often describe it as the “food noise” in their head going quiet.
In the gut, semaglutide slows how quickly your stomach empties after a meal. This keeps you feeling full longer. It also improves blood sugar control by boosting insulin release and reducing glucagon, which is why it was originally developed for diabetes.
Ozempic vs. Wegovy vs. Zepbound
Ozempic and Wegovy contain the same drug, semaglutide, but Wegovy comes in higher doses (up to 2.4 mg weekly versus Ozempic’s typical 1 to 2 mg). Wegovy is the only semaglutide with FDA approval for weight loss. If your goal is weight management rather than diabetes control, Wegovy is the version your doctor would ideally prescribe, though insurance coverage and supply shortages often complicate that.
The newer competitor, tirzepatide (sold as Zepbound for weight loss and Mounjaro for diabetes), targets two gut hormones instead of one. In a head-to-head trial sponsored by Eli Lilly, participants on Zepbound lost an average of 20.2% of their body weight (about 50 pounds) compared to 13.7% (about 33 pounds) on Wegovy over the same period. At the highest dose in separate trials, tirzepatide produced average weight loss of nearly 21%. So while semaglutide is effective, tirzepatide currently produces greater weight loss on average.
Side Effects and Tolerability
Stomach-related side effects are the main issue. In a two-year clinical trial, 82.2% of people taking semaglutide experienced mild to moderate gastrointestinal problems, compared to 53.9% on placebo. The most common are nausea, vomiting, diarrhea, abdominal pain, and constipation. In pooled trial data, about a third of patients on Ozempic reported these symptoms, versus 15% on placebo.
The good news is that these side effects are worst during the first few months while your dose is being increased. Most people find the nausea and digestive issues ease significantly after about 20 weeks of use. Starting at a low dose and gradually increasing helps your body adjust.
Ozempic carries an FDA boxed warning (the most serious type) about thyroid tumors. In animal studies, semaglutide caused thyroid C-cell tumors at doses relevant to humans. Whether this translates to a real risk in people is still unknown. The drug is not an option for anyone with a personal or family history of a specific thyroid cancer called medullary thyroid carcinoma, or a condition called Multiple Endocrine Neoplasia syndrome type 2.
What the Dosing Schedule Looks Like
Ozempic is a once-weekly injection you give yourself with a prefilled pen, typically in the stomach, thigh, or upper arm. The standard schedule starts low and builds gradually:
- Weeks 1 through 4: 0.25 mg per week (this is a starter dose, not expected to produce much weight loss)
- Weeks 5 through 8: 0.5 mg per week
- Week 9 onward: 1 mg per week, with the option to increase to 2 mg
This slow ramp-up is deliberate. It gives your digestive system time to adapt and reduces the severity of nausea. Most of the meaningful weight loss kicks in once you reach the higher maintenance doses.
Cost and Getting a Prescription
Ozempic has a list price of $1,027.51 per monthly pen, regardless of dose. What you actually pay depends entirely on your insurance plan, your deductible status, and whether the drug is on your plan’s formulary. Since Ozempic is approved for diabetes rather than weight loss, insurers generally will not cover it for weight management alone. Wegovy, while approved for weight loss, faces its own coverage restrictions.
For weight loss medications in general, doctors typically follow established eligibility criteria: a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol. If you fall below these thresholds, getting a prescription or insurance coverage becomes significantly harder.
What Happens When You Stop
This is the most important thing to understand about Ozempic for weight loss. Semaglutide does not cure obesity. It manages it. The appetite-suppressing effects last only as long as you keep taking the drug. Most people regain a significant portion of the weight they lost after stopping, because the biological signals that drive hunger return to their previous levels. For many people, this means committing to long-term or indefinite use, which makes the ongoing cost and side effect profile a real consideration in deciding whether to start.